•
May 31, 2022

Walgreens Q3 2022 Earnings Report

Walgreens reported third quarter results broadly in line with expectations, with strong execution across segments.

Key Takeaways

Walgreens Boots Alliance reported a decrease in third quarter sales by 4.2 percent to $32.6 billion. EPS decreased 73.8 percent to $0.33, while adjusted EPS decreased 30.0 percent to $0.96. The company is maintaining its full year adjusted EPS guidance of low-single digit growth.

Third quarter EPS from continuing operations decreased 73.8 percent to $0.33, compared with EPS of $1.27 in the year-ago quarter.

Third quarter sales from continuing operations decreased 4.2 percent over the year-ago quarter to $32.6 billion.

Walgreens Health pro forma sales up 65 percent compared to year-ago standalone results.

Transformational Cost Management Program now expected to deliver $3.5 billion in annual cost savings by fiscal 2024, up from $3.3 billion previously.

Total Revenue
$32.6B
Previous year: $34B
-4.2%
EPS
$0.96
Previous year: $1.38
-30.4%
Gross Profit
$6.57B
Previous year: $7.15B
-8.1%
Cash and Equivalents
$2.29B
Previous year: $1.35B
+69.9%
Free Cash Flow
$1.3B
Previous year: $1.4B
-7.1%
Total Assets
$92.8B
Previous year: $91.9B
+0.9%

Walgreens

Walgreens

Walgreens Revenue by Segment

Forward Guidance

Walgreens Boots Alliance is maintaining full year adjusted EPS guidance of low-single digit growth, as year-to-date performance is tracking broadly in line with expectations.

Revenue & Expenses

Visualization of income flow from segment revenue to net income